At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you
Shouldn't life sciences OEMs be sourcing components from companies like mine so that all the economic benefit stays in the UK?
This seems to be a lot easier to say than to actually do...finding new suppliers takes time. How do large companies source new suppliers? Are tradeshows still the preferred method?
1 person agrees with this